Sciele Pharma, Inc. Introduces OSTIVA™, A New Women’s Health Product

ATLANTA--(BUSINESS WIRE)--Sciele Pharma, Inc. (NASDAQ:SCRX) today announced the introduction of OSTIVA™, an oral prescription nutritional supplement formulation with Metafolin®, calcium, and vitamin D that gives women nutritional support to help maintain healthy bones.